Bilignost

Bilignost - General Information

A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.

Pharmacology of Bilignost

Not Available

Additional information about Bilignost

Bilignost Indication: Used as a contrast agent for cholecystography and intravenous cholangiography.
Mechanism Of Action: Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these iodinated organic compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. Bilignost's primary excretion through the hepato-biliary system and concentration in bile allows visualization of the gallbladder and biliary ducts.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Iodipamide
Synonyms: 3,3'-[(1,6-dioxohexane-1,6-diyl)diimino]bis(2,4,6-triiodobenzoic acid); Iodipamic acid; Adipiodone; Adipiodonum [INN-Latin]; Adipiodona [INN-Spanish]; IDB
Drug Category: Contrast Media
Drug Type: Small Molecule; Approved

Other Brand Names containing Iodipamide: Transbilix; Cholospect; Cholografin; Biligrafin; Bilignostum; Bilignost;
Absorption: Not Available
Toxicity (Overdose): Acute IV LD50 is 5000 mg/kg in rat, 3195 mg/kg in mouse, and 1200 mg/kg in dog.
Protein Binding: Not Available
Biotransformation: Hepatic.
Half Life: Not Available
Dosage Forms of Bilignost: Injection, solution Intravenous drip
Chemical IUPAC Name: 3-[[6-[(3-carboxy-2,4,6-triiodophenyl)amino]-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid
Chemical Formula: C20H14I6N2O6
Iodipamide on Wikipedia: Not Available
Organisms Affected: Humans and other mammals